Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kott

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Atherosclerosis|May 28, 2021
Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT studyStephen T Vernon, Katharine A Kott, Thomas Hansen, et al.
Biomolecules|August 26, 2023
Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery DiseaseKatharine A Kott, Elijah Genetzakis, Michael P Gray, et al.
International Journal of Molecular Sciences|January 11, 2024
High-Throughput Measure of Mitochondrial Superoxide Levels as a Marker of Coronary Artery Disease to Accelerate Drug Translation in Patient-Derived Endothelial Cells Using Opera Phenix<sup>®</sup> TechnologyWeiqian E Lee, Marie Besnier, Elijah Genetzakis, et al.
Journal of the American Heart Association|October 8, 2021
Association of Global Coagulation Profiles With Cardiovascular Risk Factors and Atherosclerosis: A Sex Disaggregated Analysis From the BioHEART-CT StudyKatharine A Kott, Marie-Christine Morel-Kopp, Stephen T Vernon, et al.
Journal of the American Heart Association|November 30, 2020
Single-Cell Immune Profiling in Coronary Artery Disease: The Role of State-of-the-Art Immunophenotyping With Mass Cytometry in the Diagnosis of AtherosclerosisKatharine A Kott, Stephen T Vernon, Thomas Hansen, et al.
Scientific Reports|January 27, 2026
Plasma fatty acid profiles and coronary artery disease burden assessed by coronary CT angiography: an observational studyPich Chhay, Dantong Zhu, Owen Tang, et al.
Cells|February 15, 2022
Biomarker Development in Cardiology: Reviewing the Past to Inform the FutureKatharine A Kott, Michael Bishop, Christina H J Yang, et al.
Cells|April 30, 2021
Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT StudyStephen T Vernon, Owen Tang, Taiyun Kim, et al.
Nature Communications|August 18, 2021
A hierarchical approach to removal of unwanted variation for large-scale metabolomics dataTaiyun Kim, Owen Tang, Stephen T Vernon, et al.
BMJ Open|September 21, 2019
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort studyKatharine A Kott, Stephen T Vernon, Thomas Hansen, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Atherosclerosis|May 28, 2021
Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT studyStephen T Vernon, Katharine A Kott, Thomas Hansen, et al.
Biomolecules|August 26, 2023
Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery DiseaseKatharine A Kott, Elijah Genetzakis, Michael P Gray, et al.
International Journal of Molecular Sciences|January 11, 2024
High-Throughput Measure of Mitochondrial Superoxide Levels as a Marker of Coronary Artery Disease to Accelerate Drug Translation in Patient-Derived Endothelial Cells Using Opera Phenix<sup>®</sup> TechnologyWeiqian E Lee, Marie Besnier, Elijah Genetzakis, et al.
Journal of the American Heart Association|October 8, 2021
Association of Global Coagulation Profiles With Cardiovascular Risk Factors and Atherosclerosis: A Sex Disaggregated Analysis From the BioHEART-CT StudyKatharine A Kott, Marie-Christine Morel-Kopp, Stephen T Vernon, et al.
Journal of the American Heart Association|November 30, 2020
Single-Cell Immune Profiling in Coronary Artery Disease: The Role of State-of-the-Art Immunophenotyping With Mass Cytometry in the Diagnosis of AtherosclerosisKatharine A Kott, Stephen T Vernon, Thomas Hansen, et al.
Scientific Reports|January 27, 2026
Plasma fatty acid profiles and coronary artery disease burden assessed by coronary CT angiography: an observational studyPich Chhay, Dantong Zhu, Owen Tang, et al.
Cells|February 15, 2022
Biomarker Development in Cardiology: Reviewing the Past to Inform the FutureKatharine A Kott, Michael Bishop, Christina H J Yang, et al.
Cells|April 30, 2021
Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT StudyStephen T Vernon, Owen Tang, Taiyun Kim, et al.
Nature Communications|August 18, 2021
A hierarchical approach to removal of unwanted variation for large-scale metabolomics dataTaiyun Kim, Owen Tang, Stephen T Vernon, et al.
BMJ Open|September 21, 2019
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort studyKatharine A Kott, Stephen T Vernon, Thomas Hansen, et al.
Pageof 3